Evidence map›Paper›PMID 38058760›Full record

ArticleMolecular syndromology2023

Eyyup Uctepe, Ahmet Yesilyurt, Fatma Nisa Esen, Sait Tumer, Hanifenur Mancilar, Fatma Mujgan Sonmez

Open access · greenAbstract read
In one paragraph

Article in Molecular syndromology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Genes · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eyyup UctepeAcibadem Ankara Tissue Typing Laboratory, Ankara, Turkey.
Ahmet YesilyurtAcibadem Labgen Genetic Diagnosis Center, Istanbul, Turkey.
Fatma Nisa EsenAcibadem Labgen Genetic Diagnosis Center, Istanbul, Turkey.
Sait TumerAcibadem Labgen Genetic Diagnosis Center, Istanbul, Turkey.
Hanifenur MancilarAcibadem Labgen Genetic Diagnosis Center, Istanbul, Turkey.
Fatma Mujgan SonmezKaradeniz Technical University Faculty of Medicine, Department of Child Neurology, Ankara, Turkey.
Acıbadem Adana Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hereditary forms of intellectual disability (ID), an estimated prevalence ranging between 1% and 3% in the general population, are among the most important problems in health care. Especially, autosomal-recessive ID has a very heterogeneous molecular basis and a lack of specific phenotypic features. Methods: Here, we report on two unrelated patients with autosomal-recessive ID, microcephaly, and autistic features and review the patients with TRAPPC9-related ID. Whole-exome sequencing and array CGH were performed for molecular diagnosis of the patients. Results: The first case has a microdeletion on chromosome 8q24.23-q24.3 region which is 1.7 Mb in length and includes the last 5 exons of Conclusions: Our study showed that the most consistent clinical findings for TRAPPC9-related ID are ID, microcephaly, and some structural brain MRI abnormalities. The mutations in the

Indexed as

Array CGHAutismExome sequencingIntellectual disabilityMicrocephalyTRAPPC9

Identifiers

PMID38058760
PMCPMC10697769
OpenAlexW4385621754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.